2-amino-5-iodo-isonicotinic acid | 602167-39-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-amino-5-iodo-isonicotinic acid
• 英文别名: 2-Amino-5-iodopyridine-4-carboxylic acid
• CAS: 602167-39-5
• 化学式: C₆H₅IN₂O₂
• 分子量: 264.022
• InChiKey: AAAOGAJHXJZCDY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  76.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-amino-5-iodo-isonicotinic acid 、 氯甲酸三氯甲酯 在 盐酸 作用下， 以 1,4-二氧六环 、 水 为溶剂， 生成 6-iodo-1H-pyrido[3,4-d][1,3]oxazine-2,4-dione
  参考文献：
  名称：

  Oxo-azabicyclic compounds

  摘要：

  从以下化合物中选择的一种化合物：其中：X1、X2和X3代表N或—CR3，其中R3如说明中所述，G1代表从以下式(i/a)和(i/b)中选择的基团：其中R4、R5和R6如说明中定义，G2代表从碳-碳三键、—CH═C═CH—、C═O、C═S、S(O)n1中选择的基团，其中n1表示从0到2的整数，或者从以下式(i/c)中的基团：其中Y1代表O、S、—NH或—N烷基，Y2代表O、S、—NH或—N烷基，n是从0到6的整数，m是从0到7的整数，Z1代表—CR9R10，其中R9和R10如说明中定义，A代表一个环系统，R1代表从H、烷基、烯基、炔基、可选择地取代的基团和式(i/d)中的基团中选择的一个，其中p、Z2、B、q和G3如说明中定义，以及它的光学异构体、N-氧化物和与药用酸或碱形成的加合盐，以及含有相同的药物制剂作为第13型基质金属蛋白酶的特异性抑制剂。

  公开号：

  US20030220355A1

文献信息

• OXO-AZABICYCLIC COMPOUNDS
  申请人：Warner-Lambert Company LLC

  公开号：EP1492775A2

  公开（公告）日：2005-01-05
• US6747147B2
  申请人：——

  公开号：US6747147B2

  公开（公告）日：2004-06-08
• US6894057B2
  申请人：——

  公开号：US6894057B2

  公开（公告）日：2005-05-17
• [EN] OXO-AZABICYCLIC COMPOUNDS<br/>[FR] COMPOSES OXO-AZABICYCLIQUES
  申请人：WARNER LAMBERT CO

  公开号：WO2003076417A2

  公开（公告）日：2003-09-18

  A compound selected from those of formula (I) wherein: X1, X2, and X3, represent N or -CR3 in which R3 is as described in the description, G1 represents a group selected from those of formulae (i/a) and (i/b) in which R4, R5, and R6 are as defined in the description, G2 represents a group selected from carbon-carbon triple bond, -CH=C=CH-, C=O, C=S, S(O)n1 in which nl represents an integer from 0 to 2 inclusive, or a group of formula (i/c) in which Y1 represents O, S, -NH or -Nalkyl, and Y2 represents O, S, -NH or -Nalkyl, n is an integer from 0 to 6 inclusive, and m is an integer from 0 to 7 inclusive, Z1 represents -CR9R10,wherein R9 and R10 are as defined in the description, A represents a ring system, R1 represents a group selected from H, alkyl, alkenyl, alkynyl, optionally substituted and the group of formula (i/d) in which p, Z2, B, q and G3 are as defined in the description and optionally, its optical isomers, N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix mettaloprotease.
• [EN] OXO AZABICYCLIC COMPOUNDS<br/>[FR] COMPOSES OXO AZABICYCLIQUES
  申请人：WARNER LAMBERT CO

  公开号：WO2003076416A1

  公开（公告）日：2003-09-18

  A compound selected from those of formula (I): formula (I) wherein: - X1, X2, and X3, represent N or CR3 in which R3 is as described in the description, - G1 represents a group selected from those of formulae (i/a) and (i/b): formula (II) in which R4, R5, and R6 are as defined in the description, - G2 represents a group selected from carbon-carbon triple bond, -CH=C=CH-, C=O, C=S, S(O)nt in which n1 represents an integer from 0 to 2 inclusive, or a group of formula (i/c): formula (III) in which Y1 represents O, S, -NH or Nalkyl, and Y2 represents O, S, -NH or Nalkyl, - n is an integer from 0 to 6 inclusive, and m is an integer from 0 to 7 inclusive, Z1 represents CR9R10, wherein R9 and R10 are as defined in the description, - A represents a ring system, - R1 represents a group selected from H, alkyl, alkenyl, alkynyl, optionally substituted and the group of formula (i/d): formula (IV) in which p, Z2, B, q and G3 are as defined in the description and optionally, its optical isomers, N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix mettaloprotease.